Published in Blood Weekly, December 11th, 2003
"Natural killer (NK) cell alloreactivity resulting from killer immunoglobulin-like receptor (KIR) ligand incompatibility improves outcomes in patients receiving extensively T cell-depleted bone marrow (BM) grafts," scientists writing in the British Journal of Haematology report.
"Patients with KIR ligand incompatibility are at risk for donor T cell alloreactivity. We investigated the relative significance of NK-cell and T cell alloreactivity in 105 pediatric patients who received a...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.